Atrium Therapeutics (RNA) Q4 2025 Earnings

10NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.27
-1.11
-0.95
-0.79

Details

Expected EPS
-1.085268
Actual EPS
-1.27
Surprise EPS
-0.18
Surprise Percent
+17.02%

Description

Atrium Therapeutics (RNA) has reported earnings of -1.27 per share for Q4 2025.

0 Comments

Share your thoughts